Head-to-head · WeighScore
SnagRx vs TRYM Health
By GLP-1 ScorecardUpdated
Score comparison
TRYM Health has the higher recorded score — 70.6/100 to 57.9/100.
TRYM Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TRYM Health (TRYM) is a nationwide telehealth service offering compounded GLP-1 weight-loss medication — semaglutide (~$96/mo, $3.20/day) and tirzepatide (~$126/mo, $4.20/day) — as additive-free multi-dose vials covering all doses, with a starter kit, temperature-controlled shipping, FSA/HSA eligibility, and flexible cancellation.
Before you choose
Before comparing the headline prices, the SnagRx review and the TRYM Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, SnagRx vs Vitara RX and TRYM Health vs Vitara RX compare each of them with another graded program, and the list of alternatives to SnagRx ranks the programs closest to SnagRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | SnagRx | TRYM Health |
|---|---|---|
| WeighScore | 57.9/100 | 70.6/100 |
| Grade | C | C |
| Site position | #339 | #114 |
| Semaglutide | $99/mo (one-month compounded plan) | $96/mo (all doses, compounded) |
| Tirzepatide | $149/mo (one-month compounded plan) | $126/mo (all doses, compounded) |
| Coverage | FAQ excludes Louisiana; confirm state eligibility | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #339 · C
Strengths
- One-month compounded injection plans advertised at $99 semaglutide / $149 tirzepatide
- Three-, six- and twelve-month prepaid options with published totals
- Terms name four possible pharmacy partners; individual assignment needs confirmation
- Product pages advertise evaluation, medication, coaching, messaging and shipping
What to consider
- Lowest $69/$119 monthly equivalents require $828/$1,428 twelve-month prepayments
- Final pharmacy-related charges may vary despite flat-dose marketing
- Refund policy makes payments final immediately; medical rejection refunds may deduct used services
- Cancellation cutoffs differ: five days before the prescription period ends versus 72 hours before billing
- Homepage state restrictions conflict with broader terms; confirm eligibility
FDAWarning letter issued to TRYM Health, Inc. dba TRYM Health in September 2025. See the FDA warning-letter database.
Strengths
- Affordable compounded GLP-1 — semaglutide ~$96/mo ($3.20/day) and tirzepatide ~$126/mo ($4.20/day)
- Available in all 50 states with free shipping and FSA/HSA eligibility
- Multi-dose vials cover all doses up to the maximum; additive-free, with a full starter kit
- Temperature-controlled insulated shipping and flexible cancellation
What to consider
- Compounding pharmacy partner not named
- LegitScript certification was not documented on the public pages reviewed
- Lowest per-day pricing likely requires a longer prepaid plan commitment
- Drugs labeled generically as 'GLP-1' / 'GLP-1 + GIP' on the services page rather than named
- FDA issued TRYM Health, Inc. dba TRYM Health a warning letter in September 2025; the letter is public in FDA's warning-letter database
Featured provider
SnagRx
SnagRx scores 57.9/100 (C). SnagRx lists one-month compounded injection plans at $99/$149, with prepaid discounts and refund rules to resolve before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.